KFDA set forth revaluation of 1,544 drugs next year.

The KFDA announced that the drug revaluation works would be conducted for the total 1,544 products including 240 hormone and 250 remedies for anal use, and the detailed scope of revaluation drugs are as follows:

Hormones.

-Pituitary grand hormones (24 products)
-Salivary grand hormones (2 products)
-Thyroid and parathyroid hormones (84 products)
-Anabolic steroid hormones (24 produ...